einstein (São Paulo). 20/Oct/2021;19:eCE6464.
Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
Martina Giacalone
, Marcos Roberto Tovani-Palone
, Luca Marin
, Massimiliano Febbi
, Tommaso Russano
, Andrea Giacalone
DOI: 10.31744/einstein_journal/2021CE6464
Dear Editor,
Coronavirus disease 2019 (COVID-19) patients may experience mental confusion, agitation, symptoms of depression, anxiety, and insomnia.(1) Several risk factors have been considered regarding neuropsychiatric complications of COVID-19, many of which are already known to be associated with other mental health problems.(2)
[…]
Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
364